Patents by Inventor Eiko Iwakoshi

Eiko Iwakoshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090023184
    Abstract: Tachykinin peptide isolated and purified from the posterior salivary gland Octopus vulgaris which is mollusc.
    Type: Application
    Filed: April 8, 2008
    Publication date: January 22, 2009
    Applicant: SUNTORY LIMITED
    Inventors: Hiroyuki MINAKATA, Eiko Iwakoshi, Kyoko Kuroda
  • Publication number: 20080280326
    Abstract: A novel peptide found as gonadotropin-releasing hormone (GnRH) in octopuses, a member of mollusks. The structure and the activities of the peptide have been unraveled. The peptide finds use as a reagent used in the studies of correlations between the structure and the activities of GnRH and the information processing mechanisms of the nervous systems in higher animals. It can also serve as a base compound in the development of pesticides and drugs. The peptide has the GnRH activity and has the following amino acid sequence (I): (I) <Glu-Zaa-Zaa-His-Zaa-Ser-Zaa-Zaa-Zaa-Zaa-Pro- Gly-NH2 wherein <Glu represents pyroglutamic acid and Zaa represents any amino acid. Specifically, the peptide has the following amino acid sequence (1): (1) <Glu-Asn-Tyr-His-Phe-Ser-Asn-Gly-Trp-His-Pro-Gly- NH2 wherein <Glu represents pyroglutamic acid.
    Type: Application
    Filed: April 29, 2008
    Publication date: November 13, 2008
    Applicant: SUNTORY LIMITED
    Inventors: Hiroyuki MINAKATA, Eiko Iwakoshi, Kyoko Kuroda
  • Patent number: 7381706
    Abstract: A novel peptide found as gonadotropin-releasing hormone (GnRH) in octopuses, a member of mollusks. The structure and the activities of the peptide have been unraveled. The peptide finds use as a reagent used in the studies of correlations between the structure and the activities of GnRH and the information processing mechanisms of the nervous systems in higher animals. It can also serve as a base compound in the development of pesticides and drugs. The peptide has the GnRH activity and has the following amino acid sequence (I): <Glu-Zaa-Zaa-His-Zaa-Ser-Zaa-Zaa-Zaa-Zaa-Pro-Gly-NH2 (SEQ ID NO: 7) ??(I) wherein <Glu represents pyroglutamic acid and Zaa represents any amino acid. Specifically, the peptide has the following amino acid sequence (1): <Glu-Asn-Tyr-His-Phe-Ser-Asn-Gly-Trp-His-Pro-Gly-NH2 (SEQ ID NO: 1) ??(1) wherein <Glu represents pyroglutamic acid.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: June 3, 2008
    Assignee: Suntory Limited
    Inventors: Hiroyuki Minakata, Eiko Iwakoshi, Kyoko Kuroda
  • Patent number: 7371810
    Abstract: Tachykinin peptide isolated and purified from the posterior salivary gland of the mollusk Octopus vulgaris. The tachykinin peptide provides a new approach for developing medicaments and pesticides through studies on the structural activity correlation at the molecular level, is characterized by: (1) number of amino acid residues is 12; (2) N terminal of the peptide is Lys; (3) an amino acid sequence of 5 amino acids from C-terminal is represented by the following amino acid sequence: Phe-Xaa-Gly-Leu-Met (SEQ ID NO: 6), (wherein, Xaa is Val, lie, Phe or Tyr), especially following amino acid sequences are provided: Lys-Pro-Pro-Ser-Ser-Ser-Glu-Phe-Val-Gly-Leu-Met (SEQ ID NO: 1), Lys-Pro-Pro-Ser-Ser-Ser-Glu-Phe-Ile-Gly-Leu-Met (SEQ ID NO: 2).
    Type: Grant
    Filed: July 25, 2000
    Date of Patent: May 13, 2008
    Assignee: Suntory Limited
    Inventors: Hiroyuki Minakata, Eiko Iwakoshi, Kyoko Kuroda
  • Publication number: 20050143567
    Abstract: A novel peptide found as gonadotropin-releasing hormone (GnRH) in octopuses, a member of mollusks. The structure and the activities of the peptide have been unraveled. The peptide finds use as a reagent used in the studies of correlations between the structure and the activities of GnRH and the information processing mechanisms of the nervous systems in higher animals. It can also serve as a base compound in the development of pesticides and drugs. The peptide has the GnRH activity and has the following amino acid sequence (I): <Glu-Zaa-Zaa-His-Zaa-Ser-Zaa-Zaa-Zaa-Zaa-Pro-Gly-NH2 ??(I) wherein <Glu represents pyroglutamic acid and Zaa represents any amino acid. Specifically, the peptide has the following amino acid sequence (I): <Glu-Asn-Tyr-His-Phe-Ser-Asn-Gly-Trp-His-Pro-Gly-NH2 ??(1) wherein <Glu represents pyroglutamic acid.
    Type: Application
    Filed: June 29, 2001
    Publication date: June 30, 2005
    Applicant: Suntory Limited
    Inventors: Hiroyuki Minakata, Eiko Iwakoshi, Kyoko Kuroda